Skip to content
PIL Logo

Erivedge 150 mg hard capsules

Last Updated on eMC 18-May-2017 View document  | Roche Products Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18-May-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision

Updated on 22-Nov-2016 and displayed until 18-May-2017

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 12-Oct-2016 and displayed until 22-Nov-2016

Reasons for adding or updating:

  • Change to section 3 - use in children/adolescents
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 16-Jun-2016 and displayed until 12-Oct-2016

Reasons for adding or updating:

  • Change to section 5 - how to store
  • Change to section 6 - date of revision

Updated on 27-May-2016 and displayed until 16-Jun-2016

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision

Updated on 02-Jun-2015 and displayed until 27-May-2016

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 11-May-2015 and displayed until 02-Jun-2015

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 20-Jan-2015 and displayed until 11-May-2015

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 20-Jun-2014 and displayed until 20-Jan-2015

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 05-Aug-2013 and displayed until 20-Jun-2014

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Roche Products Limited

Company image
Address

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW

Fax

+44 (0)1707 338 297

Medical Information e-mail
Medical Information Fax

+44 (0)1707 384555

Telephone

+44 (0)1707 366 000

Medical Information Direct Line

+44 (0)800 328 1629

Customer Care direct line

+44 (0)800 731 5711

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

vismodegib

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue